Table 1. Catheter-Associated Bloodstream Infection Treatment Consumption Value & CAGR: China VS Global, 2019-2030, US$ Million

Table 2. Catheter-Associated Bloodstream Infection Treatment Market Restraints

Table 3. Catheter-Associated Bloodstream Infection Treatment Market Trends

Table 4. Catheter-Associated Bloodstream Infection Treatment Industry Policy

Table 5. Global Catheter-Associated Bloodstream Infection Treatment Revenue by Company, 2019-2024, US$ million, Ranked Based on Revenue in 2022

Table 6. Global Catheter-Associated Bloodstream Infection Treatment Revenue Share by Company, 2019-2024, Ranked by Data of 2022

Table 7. Global Catheter-Associated Bloodstream Infection Treatment Sales Quantity by Company, (2019-2024) & (K Units), Ranked Based on Sales in 2022

Table 8. Global Catheter-Associated Bloodstream Infection Treatment Sales Quantity by Company, 2019-2024, Ranked by Data of 2022

Table 9. Global Catheter-Associated Bloodstream Infection Treatment Average Selling Price (ASP) by Company, (2019-2024) & (US$/Unit)

Table 10. Global Catheter-Associated Bloodstream Infection Treatment Manufacturers Market Concentration Ratio (CR3 and HHI)

Table 11. Global Catheter-Associated Bloodstream Infection Treatment Mergers & Acquisitions, Expansion Plans

Table 12. Global Catheter-Associated Bloodstream Infection Treatment Manufacturers Product Type

Table 13. Head Office and Catheter-Associated Bloodstream Infection Treatment Production Site of Key Manufacturer

Table 14. Catheter-Associated Bloodstream Infection Treatment Capacity of Major Manufacturers and Future Plan

Table 15. China Catheter-Associated Bloodstream Infection Treatment Revenue by Company, 2019-2024, US$ million, Ranked Based on Revenue in 2022

Table 16. China Catheter-Associated Bloodstream Infection Treatment Sales Quantity by Company, (2019-2024) & (K Units), Ranked Based on Sales in 2022

Table 17. China Catheter-Associated Bloodstream Infection Treatment Sales Quantity by Company, 2019-2024, Ranked by Data of 2022

Table 18. Global Catheter-Associated Bloodstream Infection Treatment Production & Forecast by Region, 2019 VS 2024 VS 2030, (K Units)

Table 19. Global Catheter-Associated Bloodstream Infection Treatment Production by Region, 2019-2024, (K Units)

Table 20. Global Catheter-Associated Bloodstream Infection Treatment Production Forecast by Region, 2024-2029, (K Units)

Table 21. Global Key Players of Catheter-Associated Bloodstream Infection Treatment Upstream (Raw Materials)

Table 22. Global Catheter-Associated Bloodstream Infection Treatment Typical Customers

Table 23. Catheter-Associated Bloodstream Infection Treatment Typical Distributors

Table 24. By Type, Global Catheter-Associated Bloodstream Infection Treatment Consumption Value & CAGR, 2019 VS 2024 VS 2030, US$ Million

Table 25. By Application, Global Catheter-Associated Bloodstream Infection Treatment Consumption Value & CAGR, 2019 VS 2024 VS 2030, US$ Million

Table 26. By Region, Global Catheter-Associated Bloodstream Infection Treatment Consumption Value, 2019 VS 2024 VS 2030, US$ Million

Table 27. By Region, Global Catheter-Associated Bloodstream Infection Treatment Consumption Value, 2019-2030, US$ Million

Table 28. By Region, Global Catheter-Associated Bloodstream Infection Treatment Sales Quantity, 2019-2030, (K Units)

Table 29. By Country, Global Catheter-Associated Bloodstream Infection Treatment Consumption Value & CAGR, 2019 VS 2024 VS 2030, US$ Million

Table 30. By Country, Global Catheter-Associated Bloodstream Infection Treatment Consumption Value, 2019-2030, US$ Million

Table 31. By Country, Global Catheter-Associated Bloodstream Infection Treatment Consumption Value Market Share, 2019-2030

Table 32. By Country, Global Catheter-Associated Bloodstream Infection Treatment Sales Quantity, 2019-2030, (K Units)

Table 33. By Country, Global Catheter-Associated Bloodstream Infection Treatment Sales Quantity Market Share, 2019-2030

Table 34. AstraZeneca Company Information, Head Office, Market Area, and Industry Position

Table 35. AstraZeneca Catheter-Associated Bloodstream Infection Treatment Models, Specifications, and Application

Table 36. AstraZeneca Catheter-Associated Bloodstream Infection Treatment Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024

Table 37. AstraZeneca Company Profile and Main Business

Table 38. AstraZeneca Recent Developments

Table 39. CorMedix, Inc. Company Information, Head Office, Market Area, and Industry Position

Table 40. CorMedix, Inc. Catheter-Associated Bloodstream Infection Treatment Models, Specifications, and Application

Table 41. CorMedix, Inc. Catheter-Associated Bloodstream Infection Treatment Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024

Table 42. CorMedix, Inc. Company Profile and Main Business

Table 43. CorMedix, Inc. Recent Developments

Table 44. Citus Pharmaceuticals Company Information, Head Office, Market Area, and Industry Position

Table 45. Citus Pharmaceuticals Catheter-Associated Bloodstream Infection Treatment Models, Specifications, and Application

Table 46. Citus Pharmaceuticals Catheter-Associated Bloodstream Infection Treatment Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024

Table 47. Citus Pharmaceuticals Company Profile and Main Business

Table 48. Citus Pharmaceuticals Recent Developments

Table 49. Fresenius Medical Care Company Information, Head Office, Market Area, and Industry Position

Table 50. Fresenius Medical Care Catheter-Associated Bloodstream Infection Treatment Models, Specifications, and Application

Table 51. Fresenius Medical Care Catheter-Associated Bloodstream Infection Treatment Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024

Table 52. Fresenius Medical Care Company Profile and Main Business

Table 53. Fresenius Medical Care Recent Developments

Table 54. Glenmark Pharmaceuticals Ltd. Company Information, Head Office, Market Area, and Industry Position

Table 55. Glenmark Pharmaceuticals Ltd. Catheter-Associated Bloodstream Infection Treatment Models, Specifications, and Application

Table 56. Glenmark Pharmaceuticals Ltd. Catheter-Associated Bloodstream Infection Treatment Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024

Table 57. Glenmark Pharmaceuticals Ltd. Company Profile and Main Business

Table 58. Glenmark Pharmaceuticals Ltd. Recent Developments

Table 59. Geistlich Pharma Company Information, Head Office, Market Area, and Industry Position

Table 60. Geistlich Pharma Catheter-Associated Bloodstream Infection Treatment Models, Specifications, and Application

Table 61. Geistlich Pharma Catheter-Associated Bloodstream Infection Treatment Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024

Table 62. Geistlich Pharma Company Profile and Main Business

Table 63. Geistlich Pharma Recent Developments

Table 64. Merck & Co., Inc. Company Information, Head Office, Market Area, and Industry Position

Table 65. Merck & Co., Inc. Catheter-Associated Bloodstream Infection Treatment Models, Specifications, and Application

Table 66. Merck & Co., Inc. Catheter-Associated Bloodstream Infection Treatment Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024

Table 67. Merck & Co., Inc. Company Profile and Main Business

Table 68. Merck & Co., Inc. Recent Developments

Table 69. Pfizer Company Information, Head Office, Market Area, and Industry Position

Table 70. Pfizer Catheter-Associated Bloodstream Infection Treatment Models, Specifications, and Application

Table 71. Pfizer Catheter-Associated Bloodstream Infection Treatment Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024

Table 72. Pfizer Company Profile and Main Business

Table 73. Pfizer Recent Developments

Table 74. TauroPhar GmbH Company Information, Head Office, Market Area, and Industry Position

Table 75. TauroPhar GmbH Catheter-Associated Bloodstream Infection Treatment Models, Specifications, and Application

Table 76. TauroPhar GmbH Catheter-Associated Bloodstream Infection Treatment Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024

Table 77. TauroPhar GmbH Company Profile and Main Business

Table 78. TauroPhar GmbH Recent Developments

Table 79. Xellia Pharmaceuticals Ltd. Company Information, Head Office, Market Area, and Industry Position

Table 80. Xellia Pharmaceuticals Ltd. Catheter-Associated Bloodstream Infection Treatment Models, Specifications, and Application

Table 81. Xellia Pharmaceuticals Ltd. Catheter-Associated Bloodstream Infection Treatment Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024

Table 82. Xellia Pharmaceuticals Ltd. Company Profile and Main Business

Table 83. Xellia Pharmaceuticals Ltd. Recent Developments

List of Figures

Figure 1. Catheter-Associated Bloodstream Infection Treatment Picture

Figure 2. Global Catheter-Associated Bloodstream Infection Treatment Consumption Value, (US$ million) & (2019-2030)

Figure 3. Global Catheter-Associated Bloodstream Infection Treatment Sales Quantity, (K Units) & (2019-2030)

Figure 4. Global Catheter-Associated Bloodstream Infection Treatment Average Selling Price (ASP), (2019-2030) & (US$/Unit)

Figure 5. China Catheter-Associated Bloodstream Infection Treatment Consumption Value, (US$ million) & (2019-2030)

Figure 6. China Catheter-Associated Bloodstream Infection Treatment Sales Quantity (K Units) & (2019-2030)

Figure 7. China Catheter-Associated Bloodstream Infection Treatment Average Selling Price (ASP), (US$/Unit) & (2019-2030)

Figure 8. By Consumption Value, China Catheter-Associated Bloodstream Infection Treatment Market Share of Global, 2019-2030

Figure 9. By Sales Quantity, China Catheter-Associated Bloodstream Infection Treatment Market Share of Global, 2019-2030

Figure 10. Global Catheter-Associated Bloodstream Infection Treatment Market Share by Company, (Tier 1, Tier 2, and Tier 3), 2022

Figure 11. China Catheter-Associated Bloodstream Infection Treatment Key Participants, Market Share, 2022

Figure 12. Global Catheter-Associated Bloodstream Infection Treatment Capacity, Production and Capacity Utilization, 2019-2030

Figure 13. Global Catheter-Associated Bloodstream Infection Treatment Capacity Market Share by Region, 2022 VS 2029

Figure 14. Global Catheter-Associated Bloodstream Infection Treatment Production Market Share & Forecast by Region, 2019-2030

Figure 15. Catheter-Associated Bloodstream Infection Treatment Industry Chain

Figure 16. Catheter-Associated Bloodstream Infection Treatment Procurement Model

Figure 17. Catheter-Associated Bloodstream Infection Treatment Sales Model

Figure 18. Catheter-Associated Bloodstream Infection Treatment Sales Channels, Direct Sales, and Distribution

Figure 19. Antibacterial Agents

Figure 20. Antibiotic

Figure 21. By Type, Global Catheter-Associated Bloodstream Infection Treatment Consumption Value, 2019-2030, US$ Million

Figure 22. By Type, Global Catheter-Associated Bloodstream Infection Treatment Consumption Value Market Share, 2019-2030

Figure 23. By Type, Global Catheter-Associated Bloodstream Infection Treatment Sales Quantity, 2019-2030, (K Units)

Figure 24. By Type, Global Catheter-Associated Bloodstream Infection Treatment Sales Quantity Market Share, 2019-2030

Figure 25. By Type, Global Catheter-Associated Bloodstream Infection Treatment Average Selling Price (ASP), 2019-2030, (US$/Unit)

Figure 26. Hospital

Figure 27. Specialist Clinic

Figure 28. Other

Figure 29. By Application, Global Catheter-Associated Bloodstream Infection Treatment Consumption Value, 2019-2030, US$ Million

Figure 30. By Application, Global Catheter-Associated Bloodstream Infection Treatment Consumption Value Market Share, 2019-2030

Figure 31. By Application, Global Catheter-Associated Bloodstream Infection Treatment Sales Quantity, 2019-2030, (K Units)

Figure 32. By Application, Global Catheter-Associated Bloodstream Infection Treatment Sales Quantity Market Share, 2019-2030

Figure 33. By Application, Global Catheter-Associated Bloodstream Infection Treatment Average Selling Price (ASP), 2019-2030, (US$/Unit)

Figure 34. By Region, Global Catheter-Associated Bloodstream Infection Treatment Consumption Value Market Share, 2019-2030

Figure 35. By Region, Global Catheter-Associated Bloodstream Infection Treatment Sales Quantity Market Share, 2019-2030

Figure 36. North America Catheter-Associated Bloodstream Infection Treatment Consumption Value & Forecasts, 2019-2030, US$ Million

Figure 37. By Country, North America Catheter-Associated Bloodstream Infection Treatment Consumption Value Market Share, 2022

Figure 38. Europe Catheter-Associated Bloodstream Infection Treatment Consumption Value & Forecasts, 2019-2030, US$ Million

Figure 39. By Country, Europe Catheter-Associated Bloodstream Infection Treatment Consumption Value Market Share, 2022

Figure 40. Asia Pacific Catheter-Associated Bloodstream Infection Treatment Consumption Value & Forecasts, 2019-2030, US$ Million

Figure 41. By Country/Region, Asia Pacific Catheter-Associated Bloodstream Infection Treatment Consumption Value Market Share, 2022

Figure 42. South America Catheter-Associated Bloodstream Infection Treatment Consumption Value & Forecasts, 2019-2030, US$ Million

Figure 43. By Country, South America Catheter-Associated Bloodstream Infection Treatment Consumption Value Market Share, 2022

Figure 44. Middle East & Africa Catheter-Associated Bloodstream Infection Treatment Consumption Value & Forecasts, 2019-2030, US$ Million

Figure 45. U.S. Catheter-Associated Bloodstream Infection Treatment Sales Quantity, 2019-2030, (K Units)

Figure 46. By Type, U.S. Catheter-Associated Bloodstream Infection Treatment Sales Quantity Market Share, 2022 VS 2029

Figure 47. By Application, U.S. Catheter-Associated Bloodstream Infection Treatment Sales Quantity Market Share, 2022 VS 2029

Figure 48. Europe Catheter-Associated Bloodstream Infection Treatment Sales Quantity, 2019-2030, (K Units)

Figure 49. By Type, Europe Catheter-Associated Bloodstream Infection Treatment Sales Quantity Market Share, 2022 VS 2029

Figure 50. By Application, Europe Catheter-Associated Bloodstream Infection Treatment Sales Quantity Market Share, 2022 VS 2029

Figure 51. China Catheter-Associated Bloodstream Infection Treatment Sales Quantity, 2019-2030, (K Units)

Figure 52. By Type, China Catheter-Associated Bloodstream Infection Treatment Sales Quantity Market Share, 2022 VS 2029

Figure 53. By Application, China Catheter-Associated Bloodstream Infection Treatment Sales Quantity Market Share, 2022 VS 2029

Figure 54. Japan Catheter-Associated Bloodstream Infection Treatment Sales Quantity, 2019-2030, (K Units)

Figure 55. By Type, Japan Catheter-Associated Bloodstream Infection Treatment Sales Quantity Market Share, 2022 VS 2029

Figure 56. By Application, Japan Catheter-Associated Bloodstream Infection Treatment Sales Quantity Market Share, 2022 VS 2029

Figure 57. South Korea Catheter-Associated Bloodstream Infection Treatment Sales Quantity, 2019-2030, (K Units)

Figure 58. By Type, South Korea Catheter-Associated Bloodstream Infection Treatment Sales Quantity Market Share, 2022 VS 2029

Figure 59. By Application, South Korea Catheter-Associated Bloodstream Infection Treatment Sales Quantity Market Share, 2022 VS 2029

Figure 60. Southeast Asia Catheter-Associated Bloodstream Infection Treatment Sales Quantity, 2019-2030, (K Units)

Figure 61. By Type, Southeast Asia Catheter-Associated Bloodstream Infection Treatment Sales Quantity Market Share, 2022 VS 2029

Figure 62. By Application, Southeast Asia Catheter-Associated Bloodstream Infection Treatment Sales Quantity Market Share, 2022 VS 2029

Figure 63. India Catheter-Associated Bloodstream Infection Treatment Sales Quantity, 2019-2030, (K Units)

Figure 64. By Type, India Catheter-Associated Bloodstream Infection Treatment Sales Quantity Market Share, 2022 VS 2029

Figure 65. By Application, India Catheter-Associated Bloodstream Infection Treatment Sales Quantity Market Share, 2022 VS 2029

Figure 66. Middle East & Africa Catheter-Associated Bloodstream Infection Treatment Sales Quantity, 2019-2030, (K Units)

Figure 67. By Type, Middle East & Africa Catheter-Associated Bloodstream Infection Treatment Sales Quantity Market Share, 2022 VS 2029

Figure 68. By Application, Middle East & Africa Catheter-Associated Bloodstream Infection Treatment Sales Quantity Market Share, 2022 VS 2029

Figure 69. Research Methodology

Figure 70. Breakdown of Primary Interviews

Figure 71. Bottom-up and Top-down Approaches

Figure 72. Top-down Approaches